6 U.S.C. · Domestic Security
6 U.S.C. § 216

Protection against potential synthetic opioid exposure

Ch. 1 — HOMELAND SECURITY ORGANIZATION
Title 6 U.S.C. ● ACTIVE Primary Source Ch. 1
Statutory Text

6 U.S.C. § 216 — Protection against potential synthetic opioid exposure

U.S.C. Title 6 - DOMESTIC SECURITY 6 U.S.C. United States Code, 2023 Edition Title 6 - DOMESTIC SECURITY CHAPTER 1 - HOMELAND SECURITY ORGANIZATION SUBCHAPTER IV - BORDER, MARITIME, AND TRANSPORTATION SECURITY Part B - U.S. Customs and Border Protection Sec. 216 - Protection against potential synthetic opioid exposure From the U.S. Government Publishing Office, www.gpo.gov

§216. Protection against potential synthetic opioid exposure

(a) In general The Commissioner of U.S. Customs and Border Protection shall issue a policy that specifies effective protocols and procedures for the safe handling of potential synthetic opioids, including fentanyl, by U.S. Customs and Border Protection officers, agents, other personnel, and canines, and to reduce the risk of injury or death resulting from accidental exposure and enhance post-exposure management. (b) Training (1) In general Together with the issuance of the policy described in subsection (a), the Commissioner of U.S. Customs and Border Protection shall require mandatory and recurrent training on the following: (A) The potential risk of opioid exposure and safe handling procedures for potential synthetic opioids, including precautionary measures such as the use of personal protective equipment during such handling. (B) How to access and administer opioid receptor antagonists, including naloxone, post-exposure to potential synthetic opioids. (C) How to use containment devices to prevent potential synthetic opioid exposure. (2) Integration The training described in paragraph (1) may be integrated into existing training under section 211(l) of this title for U.S. Customs and Border Protection officers, agents, and other personnel. (c) Personal protective equipment, containment devices, and opioid receptor antagonists Together with the issuance of the policy described in subsection (a), the Commissioner of U.S. Customs and Border Protection shall ensure the availability of personal protective equipment, opioid receptor antagonists, including naloxone, and containment devices, to all U.S. Customs and Border Protection officers, agents, other personnel, and canines at risk of accidental exposure to synthetic opioids. (d) Oversight To ensure effectiveness of the policy described in subsection (a)— (1) the Commissioner of U.S. Customs and Border Protection shall regularly monitor the efficacy of the implementation of such policy and adjust protocols and procedures, as necessary; and (2) the Inspector General of the Department shall audit compliance with the requirements of this section not less than once during the 3-year period after December 27, 2020.

(Pub. L. 107–296, title IV, §416, as added Pub. L. 116–260, div. U, title III, §302(a), Dec. 27, 2020, 134 Stat. 2291; amended Pub. L. 117–263, div. G, title LXXI, §7135(a), (b), Dec. 23, 2022, 136 Stat. 3650.)

Editorial Notes

Prior Provisions A prior section 216 of this title, Pub. L. 107–296, title IV, §416, Nov. 25, 2002, 116 Stat. 2181, related to GAO report to Congress, prior to repeal by Pub. L. 114–125, title VIII, §802(f), Feb. 24, 2016, 130 Stat. 210.

Amendments 2022—Subsec. (b)(1)(C). Pub. L. 117–263, §7135(a), added subpar. (C). Subsec. (c). Pub. L. 117–263, §7135(b), inserted ", containment devices," after "equipment" in heading and substituted ", opioid receptor antagonists, including naloxone, and containment devices" for "and opioid receptor antagonists, including naloxone" in text.

Statutory Notes and Related Subsidiaries Applicability to Other Components Pub. L. 117–263, div. G, title LXXI, §7135(c), Dec. 23, 2022, 136 Stat. 3650, provided that: "If the Secretary of Homeland Secretary determines that officers, agents, other personnel, or canines of a component of the Department of Homeland Security other than U.S. Customs and Border Protection are at risk of potential synthetic opioid exposure in the course of their duties, the head of such component shall carry out the responsibilities under section 416 of the Homeland Security Act of 2002 (6 U.S.C. 216) in the same manner and to the same degree as the Commissioner of U.S. Customs and Border Protection carries out such responsibilities."

Source: uscode.house.gov — public domain Official Source ↗
Root-LD Entity Data
◈ Machine-Readable Provenance Record Root-LD v1.0 · boisestandard.org
Federation ID
BS-USC06-SEC-6D083E
Entity Class
STATUTE / FEDERAL-CODE-SECTION
Domain Signature
boisestandard.org
Citation
6 U.S.C. § 216
Jurisdiction
Federal — United States
Status
✓ ACTIVE
Source
PRIMARY-SOURCE
Source Verified
✓ TRUE
Content Hash
8a601885b0923ed4...
Semantic Edges
Pending — corpus passes queued
The statutory text of 6 U.S.C. § 216 is reproduced from the official United States Code as published by the Office of the Law Revision Counsel of the U.S. House of Representatives (uscode.house.gov).
Navigate Corpus — Title 6
◈ Provenance
boisestandard.org United States Law U.S. Code Title 6 6 U.S.C. § 216